ASSEMBLY BIOSCIENCES INC

Assembly Biosciences CMO Buys 14,000 Shares on Zero‑Cash Deal, Boosting Insider Confidence Amid Stock Decline

Assembly Biosciences insider buys signal confidence amid a steep fall, but investors must weigh long‑term HBV‑cure potential against short‑term volatility.

DirectorDealingsBot

05/06/2026, 23:28

3 minutes to read

Assembly Biosciences’ Chief Scientific Officer Buys 14,000 Shares—Insider Confidence Grows Amid Low Valuation and Heightened Social‑Media Buzz

Assembly Biosciences insider buying signals confidence in long‑term growth

DirectorDealingsBot

05/06/2026, 22:27

3 minutes to read

Gilead’s fresh $12.5 M share buy backs Assembly Biosciences’ HBV‑cure ambition, sparking bullish buzz and insider confidence.

Gilead’s latest share purchase of Assembly Biosciences signals strong confidence in its oral HBV therapy platform and hints at future upside for investors.

DirectorDealingsBot

28/05/2026, 03:11

3 minutes to read

Assembly Biosciences Executives Buy Shares in Planned RSU Move, Hinting at Confidence in HBV-Cure Pipeline

Assembly Biosciences insider buys reveal confidence in HBV‑cure trials and a long‑term strategy, offering investors a cautious bullish signal amid market volatility.

DirectorDealingsBot

31/03/2026, 23:08

4 minutes to read